Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Fagan

Showing results (441-450 of 489) with videos related to

Pageof 49
Sort By:
Clinical Investigation|November 10, 2012
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer NetworkJohn C Morris, Paul S Aisen, Randall J Bateman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer diseaseVirginia D Buckles, Chengjie Xiong, Randall J Bateman, et al.
The Lancet. Neurology|October 26, 2016
Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Mengxuan Tang, Davis C Ryman, Eric McDade, et al.
The New England Journal of Medicine|July 13, 2012
Clinical and biomarker changes in dominantly inherited Alzheimer's diseaseRandall J Bateman, Chengjie Xiong, Tammie L S Benzinger, et al.
Neurobiology of Disease|March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer diseaseJeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Neurology|September 16, 2018
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseEric McDade, Guoqiao Wang, Brian A Gordon, et al.
The Canadian Journal of Cardiology|June 24, 2023
2023 CCS/CSE Standards for Physician Training and Maintenance of Competence in Adult Echocardiography: Executive SummaryParvathy Nair, Annabel Chen-Tournoux, Aws S Almufleh, et al.
Nature Medicine|January 22, 2019
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's diseaseOliver Preische, Stephanie A Schultz, Anja Apel, et al.
Pageof 49

Showing results (441-450 of 489) with videos related to

Sort By:
Pageof 49
Clinical Investigation|November 10, 2012
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer NetworkJohn C Morris, Paul S Aisen, Randall J Bateman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 2, 2021
Different rates of cognitive decline in autosomal dominant and late-onset Alzheimer diseaseVirginia D Buckles, Chengjie Xiong, Randall J Bateman, et al.
The Lancet. Neurology|October 26, 2016
Neurological manifestations of autosomal dominant familial Alzheimer's disease: a comparison of the published literature with the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)Mengxuan Tang, Davis C Ryman, Eric McDade, et al.
The New England Journal of Medicine|July 13, 2012
Clinical and biomarker changes in dominantly inherited Alzheimer's diseaseRandall J Bateman, Chengjie Xiong, Tammie L S Benzinger, et al.
Neurobiology of Disease|March 31, 2022
CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer diseaseJeremy F Strain, Nicolas Barthelemy, Kanta Horie, et al.
The Lancet. Neurology|December 14, 2022
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional studyAnna H Boerwinkle, Brian A Gordon, Julie Wisch, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2022
Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's diseaseGuoqiao Wang, Yan Li, Chengjie Xiong, et al.
Neurology|September 16, 2018
Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer diseaseEric McDade, Guoqiao Wang, Brian A Gordon, et al.
The Canadian Journal of Cardiology|June 24, 2023
2023 CCS/CSE Standards for Physician Training and Maintenance of Competence in Adult Echocardiography: Executive SummaryParvathy Nair, Annabel Chen-Tournoux, Aws S Almufleh, et al.
Nature Medicine|January 22, 2019
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's diseaseOliver Preische, Stephanie A Schultz, Anja Apel, et al.
Pageof 49